drugset / Trial / NCT03007004
Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Efficacy and safety of local infusion of botulinum toxin type B in patients with systemic sclerosis (SSc) with digital ulcer is evaluated by a randomized, double-blind study.
Timeline
- Start
- 2016-12-12
- Primary completion
- 2019-05-14
- Completion
- 2019-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum Toxin Type B | Unknown | 4000 iu | Subcutaneous |